| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:14:10 UTC |
|---|
| Update date | 2025-11-19 02:17:16 UTC |
|---|
| Primary ID | FDB019141 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Phosphatidylcholine |
|---|
| Description | PC(16:0/18:1(9Z)) is a phosphatidylchloline (PC). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylcholines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PC(16:0/18:1(9Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. In E. coli, PCs can be found in the integral component of the cell outer membrane. They are hydrolyzed by Phospholipases to a 2-acylglycerophosphocholine and a carboxylate. |
|---|
| CAS Number | 6753-55-5 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 1-16:0-2-18:1-Phosphatidylcholine | ChEBI | | 1-Hexadecanoyl-2-oleoyl-sn-glycero-3-phosphocholine | ChEBI | | 1-Palmitoyl-2-oleoyl-GPC | ChEBI | | 1-Palmitoyl-2-oleoyl-GPC (16:0/18:1) | ChEBI | | 1-Palmitoyl-2-oleoyl-lecithin | ChEBI | | 1-Palmitoyl-2-oleoylphosphatidylcholine | ChEBI | | 1-Palmotoyl-2-oleoylglycero-3-phosphocholine | ChEBI | | 1-POPC | ChEBI | | 16:0-18:1-PC | ChEBI | | GPC(16:0/18:1) | ChEBI | | GPCho(16:0/18:1) | ChEBI | | GPCho(16:0/18:1omega9) | ChEBI | | GPCho(34:1) | ChEBI | | Lecithin | ChEBI | | Palmitoyloleoylphosphatidylcholine | ChEBI | | PC(16:0/18:1) | ChEBI | | PC(16:0/18:1omega9) | ChEBI | | PC(34:1) | ChEBI | | Phosphatidylcholine(16:0/18:1) | ChEBI | | Phosphatidylcholine(16:0/18:1omega9) | ChEBI | | Phosphatidylcholine(34:1) | ChEBI | | 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine | MeSH | | alpha-Phosphatidylcholine-beta-oleoyl-gamma-palmitoyl | MeSH | | 1-Palmitoyl-2-oleoyl-phosphatidylcholine | MeSH | | 1-Palmitoyl-2-oleoylphosphatidylcholine, (R)-(Z)-isomer | MeSH | | POPC Lipid | MeSH | | beta-Oleoyl-gamma-palmitoyl-L-alpha-phosphatidylcholine | MeSH | | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine | Lipid Annotator, MeSH, HMDB | | 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine | Lipid Annotator, HMDB | | PC(16:0/18:1(9Z)) | Lipid Annotator, ChEBI | | 1-Palmitoyl-2-oleoyl-3-sn-phosphatidylcholine | HMDB | | 1-Palmitoyl-2-oleoyl-L-alpha-lecithin | HMDB | | 1-Palmitoyl-2-oleoyl-L-alpha-phosphatidylcholine | HMDB | | 1-Palmitoyl-2-oleoyl-L-α-lecithin | HMDB | | 1-Palmitoyl-2-oleoyl-L-α-phosphatidylcholine | HMDB | | 1-Palmitoyl-2-oleoyl-sn-3-phosphocholine | HMDB | | 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphorylcholine | HMDB | | 1-Palmitoyl-2-oleoyl-sn-glycero-phosphatidylcholine | HMDB | | 1-Palmitoyl-2-oleoyl-sn-glycero-phosphocholine | HMDB | | 1-Palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylcholine | HMDB | | 1-Palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine | HMDB | | 1-Palmitoyl-2-oleoyl-sn-glyceryl-3-phosphorylcholine | HMDB | | 1-Palmitoyl-2-oleoyllecithin | HMDB | | 1-Palmitoyl-2-oleyl-3-sn-phosphatidylcholine | HMDB | | 2-Oleo-1-palmitin phosphate choline ester | HMDB | | 2-Oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine | HMDB | | 2-Oleoyl-1-palmitoyllecithin | HMDB | | GPC(16:0/18:1(9Z)) | HMDB | | GPC(16:0/18:1n9) | HMDB | | GPC(16:0/18:1w9) | HMDB | | GPC(34:1) | HMDB | | GPCho(16:0/18:1(9Z)) | HMDB | | GPCho(16:0/18:1n9) | HMDB | | GPCho(16:0/18:1w9) | HMDB | | L-1-Palmitoyl-2-oleoylphosphatidylcholine | HMDB | | L-Palmitoyloleoylphosphatidylcholine | HMDB | | L-alpha-1-Palmitoyl-2-oleoylphosphatidylcholine | HMDB | | L-α-1-Palmitoyl-2-oleoylphosphatidylcholine | HMDB | | PC(16:0/18:1n9) | HMDB | | PC(16:0/18:1w9) | HMDB | | POPC | HMDB | | Phosphatidylcholine(16:0/18:1(9Z)) | HMDB | | Phosphatidylcholine(16:0/18:1n9) | HMDB | | Phosphatidylcholine(16:0/18:1w9) | HMDB | | β-Oleoyl-γ-palmitoyl-L-α-phosphatidylcholine | HMDB | | 1,2-Diacyl-sn-glycero-3-phosphocholine | biospider | | 1,2-Diacylglycero-3-phosphocholine | db_source | | 3-sn-Phosphatidylcholine | biospider | | Choline phosphatide | biospider | | Diacyllecithin | db_source | | Diacylphosphatidylcholine | db_source | | E322 | db_source | | Granulestin | db_source | | Kelecin | db_source | | Lecithol | db_source | | Vitellin | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C42H82NO8P |
|---|
| IUPAC name | (2-{[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium |
|---|
| InChI Identifier | InChI=1S/C42H82NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h20-21,40H,6-19,22-39H2,1-5H3/b21-20-/t40-/m1/s1 |
|---|
| InChI Key | WTJKGGKOPKCXLL-VYOBOKEXSA-N |
|---|
| Isomeric SMILES | CCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC |
|---|
| Average Molecular Weight | 760.0761 |
|---|
| Monoisotopic Molecular Weight | 759.577805117 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphocholines |
|---|
| Direct Parent | Phosphatidylcholines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Diacylglycero-3-phosphocholine
- Phosphocholine
- Fatty acid ester
- Dialkyl phosphate
- Dicarboxylic acid or derivatives
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Fatty acyl
- Quaternary ammonium salt
- Tetraalkylammonium salt
- Carboxylic acid ester
- Carboxylic acid derivative
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Amine
- Organic salt
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Ontology | No ontology term |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Not Available | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | Not Available | |
|---|
| Melting Point | Not Available | |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | Not Available |
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - QqQ 1V, negative | splash10-000t-0090200800-c8db3c4042d858672ebd | 2020-07-21 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - IT 40V, negative | splash10-0006-0020000900-603012fb0ce5ff46f1ea | 2020-07-21 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 24V, negative | splash10-0udi-0000000190-afc4cd2ac0e64fa39623 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 30V, negative | splash10-0udl-0000000490-09171592a6955e57e163 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 36V, negative | splash10-0f6x-0000000940-3b9edba3cc0cdfff4945 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 42V, negative | splash10-0006-0030000910-e80b4b8f6690eea16c9d | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 48V, negative | splash10-000x-0090000700-527aadfe756a5f2ad9a5 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 54V, negative | splash10-053r-0090000200-e27632edecd3a83538a4 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 60V, negative | splash10-053r-0090000000-875a5d38cc2b636df4a1 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 72V, negative | splash10-053r-0090000000-6bdad7ea857755dad8df | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 91V, negative | splash10-053r-0090000000-a0160ca0a20b8ca408de | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 109V, negative | splash10-053r-0090000000-d2bc446076d9d86bbadf | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 133V, negative | splash10-053r-1090000000-a94d8052959d35d3d25e | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 157V, negative | splash10-057i-5190000000-12de950663c450d5ad7f | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 194V, negative | splash10-004i-9000000000-906a0ebc0dd0220ac288 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - n/a 53V, negative | splash10-0006-0000000900-0bfd0ce87b7b119d82fb | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 22V, negative | splash10-0006-0000000900-88f30608c9fd0df934c2 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 28V, negative | splash10-0006-0000000900-fb159b53855796db7d35 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 34V, negative | splash10-0006-0000000900-084480cec1d6930fa834 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 41V, negative | splash10-0006-0020000900-103adeac53f876868122 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 47V, negative | splash10-000x-0090000800-a9198efdf2f4fe5ec5da | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 53V, negative | splash10-053r-0090000200-9df170809bae304c6bc1 | 2020-07-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0000000900-64875131a83d4fda43e6 | 2017-10-04 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03e9-0600000900-dfb450caf9537c97446e | 2017-10-04 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0fai-1900230300-31ec54e207b217422a2e | 2017-10-04 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 4593686 |
|---|
| ChEMBL ID | Not Available |
|---|
| KEGG Compound ID | C00157 |
|---|
| Pubchem Compound ID | 5497103 |
|---|
| Pubchem Substance ID | 3457 |
|---|
| ChEBI ID | 49183 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB0007972 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | LRV43-T:LRV43-T |
|---|
| EAFUS ID | 2000 |
|---|
| Dr. Duke ID | LECITHIN|PHOSPHATIDYL-CHOLINE |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | rw1099111 |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Phosphatidylcholine |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti-Alzheimeran | 52217 | An agent that inhibits the progression of Alzheimer's disease, reducing beta-amyloid plaque formation and neuroinflammation. Therapeutically, it improves cognitive function and memory, commonly used in managing mild to moderate Alzheimer's disease and other neurodegenerative disorders. | DUKE | | Anti ataxic | | An agent that stimulates movement coordination centers, such as the cerebellum, to treat ataxia, improving balance and motor function, commonly used in managing neurological disorders like multiple sclerosis and spinocerebellar ataxia. | DUKE | | Anti-cirrhotic | 52217 | An agent that prevents or treats liver cirrhosis, reducing fibrosis and promoting liver health. It inhibits liver scarring, commonly used in managing liver diseases such as hepatitis and fatty liver disease. | DUKE | | Anti-dementia | 52217 | An agent that slows or prevents cognitive decline, reducing symptoms of dementia. It plays a biological role in neuroprotection, enhancing neuronal function and survival. Therapeutically, it is used to manage Alzheimer's disease, vascular dementia, and other neurodegenerative disorders, improving memory, cognition, and daily functioning. | DUKE | | Anti dyskinetic | | An agent that relieves or prevents dyskinesia, improving voluntary movement. It plays a biological role in regulating motor function, and has therapeutic applications in managing Parkinson's disease, Huntington's disease, and other movement disorders, reducing involuntary movements and improving motor control. | DUKE | | Anti eczemic | 52217 | An agent that reduces inflammation and itching, commonly used to manage eczema symptoms, atopic dermatitis, and other skin allergies, providing relief and preventing flare-ups. | DUKE | | Anti-lithic | | An agent that prevents the formation of calculi (kidney stones) or promotes their dissolution, playing a key role in urology. Its therapeutic applications include managing kidney stone disease, nephrolithiasis, and urinary tract disorders, helping to alleviate pain and prevent complications. | DUKE | | Anti-manic | | An agent that stabilizes mood by controlling symptoms of mania, used to manage bipolar disorder, reducing excessive excitement and impulsivity, and preventing manic episodes. | DUKE | | Anti-morphinistic | | An agent that blocks morphine's activation of the mu opioid receptor, used to treat morphine addiction (morphinism) and manage opioid withdrawal symptoms, reducing dependence and cravings. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti-psoriac | 52217 | An agent that reduces psoriasis symptoms, commonly used in managing plaque psoriasis, scalp psoriasis, and other inflammatory skin conditions, by inhibiting cell growth, reducing inflammation, and modulating the immune system. | DUKE | | Anti-sclerodermic | 50177 | An agent that prevents or treats scleroderma, a condition characterized by hardened skin and connective tissue. It reduces fibrosis and inflammation, commonly used in managing scleroderma, pulmonary fibrosis, and other fibrotic diseases, improving skin and organ function. | DUKE | | Anti-seborrheic | 52217 | An agent that reduces seborrheic dermatitis symptoms, commonly used in managing scalp and skin conditions, such as dandruff, itching, and flaking, by inhibiting fungal growth and inflammation. | DUKE | | Anti-sprue | | An antibody associated with celiac sprue, an autoimmune disorder of the small intestine. Its biological role is in immune response, and it has therapeutic applications in diagnosing and monitoring celiac disease, with key medical uses in managing gluten intolerance and intestinal inflammation. | DUKE | | Anti-Tourette's | 52217 | An agent that reduces tic symptoms, commonly used in managing Tourette's syndrome, with a biological role in regulating neurotransmitter imbalance, and therapeutic applications in reducing involuntary movements and vocalizations, with key medical uses including treatment of tic disorders and associated conditions. | DUKE | | Antitumor | 35610 | An agent that inhibits tumor growth and proliferation, playing a crucial role in cancer treatment. Therapeutically, antitumors are used to manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, helping to reduce tumor size, prevent metastasis, and improve patient outcomes. | DUKE | | Cholinergic | 38323 | An agent that stimulates the parasympathetic nervous system by mimicking acetylcholine, enhancing muscle contraction, and regulating various bodily functions. Therapeutically, it treats conditions like glaucoma, myasthenia gravis, and Alzheimer's disease, improving muscle tone, cognition, and eye pressure. | DUKE | | Hepatoprotective | 62868 | An agent that protects the liver from damage, promoting liver health and function. It plays a biological role in reducing oxidative stress and inflammation, and has therapeutic applications in managing liver diseases, such as hepatitis and cirrhosis, and key medical uses in treating drug-induced liver injury and toxicities. | DUKE | | Hypocholesterolemic | | An agent that lowers cholesterol levels in the blood, playing a crucial role in preventing cardiovascular disease. Therapeutically, it is used to manage hyperlipidemia and reduce the risk of heart disease, with key medical applications including the treatment of high cholesterol, atherosclerosis, and coronary artery disease. | DUKE | | Lipotropic | | A compound that facilitates fat breakdown and metabolism, playing a biological role in lipid utilization. Therapeutically, it's used to enhance weight loss and improve liver function. Key medical applications include treating fatty liver disease, obesity, and hyperlipidemia, making it a valuable agent in managing metabolic disorders. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| bland |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
|
|
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|